AKR1C1 抗体
(Dihydrodiol Dehydrogenase (DDH))
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reaction of progesterone to the inactive form 20-alpha-hydroxy-progesterone. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| AKR1C1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 (AA 30-110) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 99-148) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 50-99) | 人, 猴 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 1-323) | 人 | 小鼠 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 219-323) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 219-323) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 (AA 219-323) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 大鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 大鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 大鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 大鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人, 小鼠, 豚鼠, Hamster | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C1 抗体 (AA 27-123) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 30-110
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 99-148
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 50-99
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-323
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 219-323
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 219-323
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 219-323
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 27-123
Latest Publications for our AKR1C1 抗体
: "The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer." in: Theranostics, Vol. 10, Issue 5, pp. 2188-2200, (2020) (PubMed).
: "Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism." in: Frontiers in physiology, Vol. 10, pp. 833, (2019) (PubMed).
: "AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer." in: Theranostics, Vol. 8, Issue 3, pp. 676-692, (2018) (PubMed).
: "Cisplatin resistance in human cervical, ovarian and lung cancer cells." in: Cancer chemotherapy and pharmacology, Vol. 75, Issue 6, pp. 1217-27, (2015) (PubMed).
: "An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells." in: Oncogene, Vol. 33, Issue 9, pp. 1198-206, (2014) (PubMed).
: "The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing." in: PLoS ONE, Vol. 9, Issue 9, pp. e107158, (2014) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells." in: Oncogene, Vol. 27, Issue 13, pp. 1916-29, (2008) (PubMed).
: "Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease." in: The European journal of neuroscience, Vol. 11, Issue 6, pp. 1988-94, (1999) (PubMed).
: "Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting." in: The Journal of biological chemistry, Vol. 273, Issue 48, pp. 31633-6, (1998) (PubMed).
: "Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism." in: Frontiers in physiology, Vol. 10, pp. 833, (2019) (PubMed).
: "AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer." in: Theranostics, Vol. 8, Issue 3, pp. 676-692, (2018) (PubMed).
: "Cisplatin resistance in human cervical, ovarian and lung cancer cells." in: Cancer chemotherapy and pharmacology, Vol. 75, Issue 6, pp. 1217-27, (2015) (PubMed).
: "An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells." in: Oncogene, Vol. 33, Issue 9, pp. 1198-206, (2014) (PubMed).
: "The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing." in: PLoS ONE, Vol. 9, Issue 9, pp. e107158, (2014) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells." in: Oncogene, Vol. 27, Issue 13, pp. 1916-29, (2008) (PubMed).
: "Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease." in: The European journal of neuroscience, Vol. 11, Issue 6, pp. 1988-94, (1999) (PubMed).
: "Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting." in: The Journal of biological chemistry, Vol. 273, Issue 48, pp. 31633-6, (1998) (PubMed).
Aliases for AKR1C1 抗体
aldo-keto reductase family 1 member C1 (AKR1C1) 抗体aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1) 抗体
2-ALPHA-HSD 抗体
20-ALPHA-HSD 抗体
C9 抗体
DD1 抗体
DD1/DD2 抗体
DDH 抗体
DDH1 抗体
H-37 抗体
HAKRC 抗体
HBAB 抗体
MBAB 抗体
您还需要查找其他产品吗？
- AKR1B10 抗体
- AKR1B1 抗体
- AKR1A1 抗体
- AKNA Domain Containing 1 抗体
- AKNA 抗体
- AKIRIN2 抗体
- AKIP1 抗体
- AKAP9 抗体
- AKAP8L 抗体
- AKAP8 抗体
- AKAP7 抗体
- AKAP6 抗体
- AKAP5 抗体
- AKAP4 抗体
- AKAP3 抗体
- AKAP2 抗体
- AKAP14 抗体
- AKAP13 抗体
- AKAP12 抗体
- AKAP11 抗体
- AKR1C2 抗体
- AKR1C3 抗体
- AKR1C4 抗体
- AKR1D1 抗体
- AKR1E2 抗体
- AKR7A2 抗体
- AKR7A3 抗体
- AKT Interacting Protein 抗体
- AKT2 抗体
- AKT3 抗体
- ALAD 抗体
- Alanine Glyoxylate Aminotransferase 抗体
- Alanyl (Membrane) Aminopeptidase 抗体
- Alanyl-tRNA Synthetase 抗体
- ALAS1 抗体
- ALAS2 抗体
- Albumin 抗体
- Alcohol Dehydrogenase 抗体
- Alcohol Dehydrogenase 7 (Class IV), mu Or sigma Polypeptide 抗体
- Aldehyde Dehydrogenase 抗体
You are here:
